US domestic manufacturing investment, R&D model shifts, new excipients, and digital traceability are redefining drug ...

The new partnership will work to embed digital identification into labware, solving chain-of-identity challenges for ...

For pharmaceutical manufacturers, the most immediate and critical application of RWE is in monitoring post-market safety. The ...

In episode 27, Christopher Hopkins, PhD; Omkar Kawalekar, PhD; Barnaby Pickering; and Jerry Rosenbaum, MD, go behind the ...

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

At CPHI and AAPS, Ashland plans to detail the impacts of its advanced excipients: ultra-low nitrite materials curb ...

The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...

This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...

ICE Pharma will present its bile acid-derived innovations and sustainability strategies at CPHI Frankfurt 2025. The company's ...

Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...

As the conference approaches, scientists are reviewing new technologies that enhance manufacturing process control, product ...